These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10821083)

  • 41. Does glycemic control of type II diabetes suffice to control diabetic dyslipidemia? A community perspective.
    Stern MP; Mitchell BD; Haffner SM; Hazuda HP
    Diabetes Care; 1992 May; 15(5):638-44. PubMed ID: 1516483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation between Cystatin C and retinopathy of type-two diabetes mellitus patients.
    Qian C; Wan GM; Yan PS; Wang WZ; Liang SZ; Dong Y
    J Biol Regul Homeost Agents; 2017; 31(1):99-103. PubMed ID: 28337877
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia.
    Frost RJ; Otto C; Geiss HC; Schwandt P; Parhofer KG
    Am J Cardiol; 2001 Jan; 87(1):44-8. PubMed ID: 11137832
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation studies between concentrations of glycosylated haemoglobins and lipids in non-insulin-dependent Nigerian diabetics.
    Erasmus RT; Olukoga O; Adelowo O; Adewoye HO
    Cent Afr J Med; 1986 Oct; 32(10):231-6. PubMed ID: 3652181
    [No Abstract]   [Full Text] [Related]  

  • 45. Investigation of the relationship between patient empowerment and glycaemic control in patients with type 2 diabetes: a cross-sectional analysis.
    Fitzgerald M; O'Tuathaigh C; Moran J
    BMJ Open; 2015 Dec; 5(12):e008422. PubMed ID: 26685021
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM. A multicenter comparison study.
    Tikkanen MJ; Laakso M; Ilmonen M; Helve E; Kaarsalo E; Kilkki E; Saltevo J
    Diabetes Care; 1998 Apr; 21(4):477-81. PubMed ID: 9571327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence, patterns and predictors of dyslipidaemia in Nigeria: a report from the REMAH study.
    Chori B; Danladi B; Nwakile P; Okoye I; Abdullahi U; Zawaya K; Essien I; Sada K; Nwegbu M; Ogedengbe J; Aje A; Isiguzo G; Odili A
    Cardiovasc J Afr; 2022 Mar-Apr 23; 33(2):52-59. PubMed ID: 34779815
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipids and Lp(a) lipoprotein levels and coronary artery disease in subjects with non-insulin-dependent diabetes mellitus.
    O'Brien T; Nguyen TT; Harrison JM; Bailey KR; Dyck PJ; Kottke BA
    Mayo Clin Proc; 1994 May; 69(5):430-5. PubMed ID: 8170193
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atorvastatin for the management of Type 2 diabetic patients with dyslipidaemia. A mid-term (9 months) treatment experience.
    Velussi M; Cernigoi AM; Tortul C; Merni M
    Diabetes Nutr Metab; 1999 Dec; 12(6):407-12. PubMed ID: 10782562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [La educación multimedia como apoyo en el manejo de pacientes con diabetes tipo 2. Estudio cuasi experimental].
    Aguila IP; Velázquez-López L; Goycochea-Robles MAV; Angulo-Angulo F; Peña JE
    Cir Cir; 2018; 86(5):404-411. PubMed ID: 30226499
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Meal replacement reduces insulin requirement, HbA1c and weight long-term in type 2 diabetes patients with >100 U insulin per day.
    Kempf K; Schloot NC; Gärtner B; Keil R; Schadewaldt P; Martin S
    J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():21-7. PubMed ID: 23909831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
    Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS
    Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications.
    Kesavulu MM; Giri R; Kameswara Rao B; Apparao C
    Diabetes Metab; 2000 Nov; 26(5):387-92. PubMed ID: 11119018
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of a behavioral weight loss program stressing calorie restriction versus calorie plus fat restriction in obese individuals with NIDDM or a family history of diabetes.
    Pascale RW; Wing RR; Butler BA; Mullen M; Bononi P
    Diabetes Care; 1995 Sep; 18(9):1241-8. PubMed ID: 8612437
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular risk factors and LDL subfraction profile in Type 2 diabetes mellitus subjects with good glycaemic control.
    Tan CE; Chew LS; Chio LF; Tai ES; Lim HS; Lim SC; Jayakumar L; Eng HK; Packard CJ
    Diabetes Res Clin Pract; 2001 Feb; 51(2):107-14. PubMed ID: 11165690
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus.
    Artha IMJR; Bhargah A; Dharmawan NK; Pande UW; Triyana KA; Mahariski PA; Yuwono J; Bhargah V; Prabawa IPY; Manuaba IBAP; Rina IK
    Vasc Health Risk Manag; 2019; 15():149-157. PubMed ID: 31239693
    [No Abstract]   [Full Text] [Related]  

  • 57. Lipoprotein analyses in varying degrees of glucose tolerance. Comparison between non-insulin-dependent diabetic, impaired glucose tolerant, and control populations.
    Falko JM; Parr JH; Simpson RN; Wynn V
    Am J Med; 1987 Oct; 83(4):641-7. PubMed ID: 3674053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glycaemic control and obesity are the major determinants of diabetic dyslipidaemia in Hong Kong Chinese.
    Ko GT; Cockram CS; Critchley JA; Chan JC
    Diabetes Metab; 2001 Dec; 27(6):637-44. PubMed ID: 11852371
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of improved periodontal health on metabolic control in type 2 diabetes mellitus.
    Kiran M; Arpak N; Unsal E; Erdoğan MF
    J Clin Periodontol; 2005 Mar; 32(3):266-72. PubMed ID: 15766369
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma lipid profiles in relation to diabetic control in Nigerians.
    Akanji AO; Agbedana EO; Ugbode C
    Afr J Med Med Sci; 1989 Sep; 18(3):229-34. PubMed ID: 2551165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.